These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2602057)

  • 1. [Therapeutic and immunomodulating effects of T-activin in frequently ailing children with acute pneumonia].
    Botvin'eva VV; Botvin'ev OK; Abdullaev AR; Gumbatov LD
    Pediatriia; 1989; (10):107-8. PubMed ID: 2602057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-immunological evaluation of using T-activin in children with obstructive bronchitis (data of immediate and late studies)].
    Eiubova AA; Budagov FG; Rzakulieva DM
    Pediatriia; 1991; (1):108. PubMed ID: 2041682
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
    Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenetic indicators in protracted hepatitis and their dynamics during the treatment with T-activin].
    Stanevicha VA; Veksler KhM
    Pediatriia; 1991; (10):44-8. PubMed ID: 1787998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of T-activin in viral myocarditis in animal experiments].
    Kipshidze NN; Dzhaparidze MM; Bulusashvili RV; Khuchua AV; Zbiadadze NA
    Biull Eksp Biol Med; 1988 Jun; 105(6):705-7. PubMed ID: 3260519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Dzhaparidze MM; Dzidziguri LM; Rachvelishvili NB; Dateshidze MN; Demetrashvili MF
    Ter Arkh; 1990; 62(9):116-8. PubMed ID: 2177920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience in the use of T-activin in patients with malignant testicular tumors and patients with kidney cancer].
    Geveling NV; Zhogoleva IB
    Vopr Onkol; 1986; 32(8):98-103. PubMed ID: 2429445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy using T-activin in chronic viral hepatitis B in children].
    Nisevich NI; Uchaĭkin VF; Arion VIa; Cherednichenko TV; Shkliar GM
    Sov Med; 1986; (12):55-9. PubMed ID: 3563706
    [No Abstract]   [Full Text] [Related]  

  • 12. [Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
    Zaĭrat'iants OV; Kolobov SV; Iarema IV; Shevchenko VP
    Arkh Patol; 2002; 64(6):51-6. PubMed ID: 12534231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
    Sakhelashvili-Haladzhun MI
    Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Typical immune system responses to differential monotherapy with immune-correcting drugs].
    Zemskov AM; Zemskov BM; Zoloedov VI; Lutskii MA
    Fiziol Cheloveka; 2001; 27(4):97-103. PubMed ID: 11573419
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental rationale for the use of T-activin for correction of immunodeficiency in the treatment of periapical inflammation].
    Volozhin AI; Arion VIa; Zyrianov GV; Krotova SB; Sysoeva OB
    Patol Fiziol Eksp Ter; 1994; (2):19-20. PubMed ID: 8078682
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
    Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
    Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of neutrophils in the pathogenesis of psoriasis and the effect of T-activin on them].
    Korotkiĭ NG; Udzhukhu VIu; Vasil'eva LL; Redchenko EB; Bagandov TI
    Vestn Dermatol Venerol; 1987; (7):19-22. PubMed ID: 3673241
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunobiology of thymus peptides: T-activin].
    Arion VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):98-104. PubMed ID: 3300113
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunocorrective therapy of pyelonephritis in children].
    Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP
    Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.